Embryo implantation is a complex interaction between maternal endometrium and embryonic structures. Failure to implant is highly recurrent and impossible to diagnose. Inflammation and infections in the female reproductive tract are common causes of infertility, embryo loss, and preterm labor. The current work describes how the activation of endometrial Toll-like receptor (TLR) 2 and 2/6 reduces embryo implantation chances. We developed a morphometric index to evaluate the effects of the TLR 2/6 activation along the uterine horn (UH). TLR 2/6 ligation reduced the endometrial myometrial and glandular indexes and increased the luminal index. Furthermore, TLR 2/6 activation increased the proinflammatory cytokines such as interleukin (IL)-1beta and monocyte chemotactic protein (MCP)-1 in UH lavages in the preimplantation day and IL-1 receptor antagonist in the implantation day. The engagement of TLR 2/6 with its ligand in the UH during embryo transfer severely affected the rate of embryonic implantation (45.00% 6 6.49% vs. 16.69% 6 5.01%, P , 0.05, control vs. test, respectively). Furthermore, this interference with the embryo implantation process was verified using an in vitro model of human embryo implantation where trophoblast spheroids failed to adhere to a monolayer of TLR 2-and TLR 2/6-activated endometrial cells. The inhibition of TLR receptors 2 and 6 in the presence of their specific ligands restored the ability of the spheroids to bind to the endometrial cells. In conclusion, the activation of the innate immune system in the uterus at the time of implantation interfered with the endometrial receptivity and reduced the chances of implantation success.
INTRODUCTION
Embryonic implantation is a critical event leading to a successful pregnancy [1] . The implantation process requires a complex orchestration of cellular and molecular events that include expression of adhesion molecules, remodeling of the uterine extracellular matrix, and an intricate cross-talk of hormones, cytokines, and growth factors between the embryo and the endometrium [2] [3] [4] [5] [6] . The immune system plays an important role in the modulation of the mechanisms involved in implantation. Pregnancy represents an immunological contradiction in which a semiallogeneic foreign entity, the embryo, is not rejected by the maternal immune system but accepted and nourished. This is achieved by several mechanisms, including the modulation of the maternal immune system by the preimplantation embryo [7] . Consequently, any interference that may imbalance the immune system responses could result in embryo loss and infertility. In fact, many infertility problems in women are associated with infections of the upper female reproductive tract (FRT) compartments: endocervix, fallopian tubes, and uterus. The pathogens responsible for sexually transmitted diseases (STD) such as Mycoplasma genitalium, Neisseria gonorrhoeae, and Chlamydia trachomatis have been associated with infertility in women [1, 8] .
The FRT is able to respond against these pathogenic entities and initiate an immune response. The initial recognition of pathogens in the FRT is mediated by the innate immune system of epithelial, resident dendritic, and natural killer cells [3, 7, 9] . This innate response will later prime and instruct the adaptive immune system to initiate cellular and humoral responses against the pathogens [7, 9, 10] . In order to detect the potential pathogens, endometrial epithelial cells express pattern-recognition receptors to common pathogen-associated molecular patterns (PAMPs). One of the main families of patternrecognition receptors is the TLR family [9, 11] . They can recognize a great variety of PAMPs from bacterial, fungal, parasitical, and viral origin. The TLR family is formed by 10 members where each responds to a specific ligand that promotes the secretion of a different subset of cytokines and chemokines [12] [13] [14] [15] . TLR 2 and its heterodimers with TLR 1 and TLR 6 can sense a great variety of PAMPs from pathogens that might be present in the FRT and can be activated by peptidoglycans (PGNs) from bacteria (C. trachomatis, Staphylococcus aureus, N. gonorrhoeae, and M. genitalium lipoproteins) [16] , yeast (Candida albicans phospholipomannan) [17] , and parasites (Trichomonas vaginalis lipophosphoglycan) [18] . The heterodimer of TLR 2 and TLR 6 has been found to recognize the macrophage-activated lipoprotein derived from Mycoplasma fermentans (MALP-2) [19] . FSL-1 is a specific and potent ligand for the heterodimer TLR 2/6 and was synthesized based on the MALP-2 structure by changing its amino acid sequence [20] . The ligation of TLRs activates signaling pathways that end up activating the transcription factors nuclear factor (NF)-jB or AP-1 that promote the activation of proinflammatory genes [21] .
The expression of TLRs 1-10 has been observed in mammalian uterus and in different human endometrial epithelial cell lines [13] . This expression follows the menstrual hormonal cycle. The highest level of TLR expression in the human endometrium has been observed during the late secretory phase, when implantation of the embryo takes place [22] . Although TLRs have been observed to be involved in a number of pregnancy disorders such as preterm labor, early pregnancy loss, and preeclampsia [23] , not much is known about their function during embryo implantation. Recent results from our laboratory have shown that activation of TLR5 by its ligand flagellin can interfere with trophoblast spheroids adhesion to epithelial cells in vitro [24] .
The study of the human embryo implantation process in vivo is limited because of anatomical and physiological restrictions as well as ethical and legal issues surrounding experimentation with human embryos. For these reasons, research on the embryo implantation has opted to employ different animal model species. The human embryo implantation is an invasive process, which makes it different from that of other mammalian species. The closest in vivo model to human is primate embryo implantation [25] , but the manipulation of these species is also limited due to ethical responsibility. The murine model is a good animal model that shares similar implantation characteristics with human embryo implantation such as its invasiveness [26] . It also offers many advantages like the possibility of manipulating the gametes and estrous cycle (between 4 to 5 days) and a short gestation (approx. 3 wk) [27] . Implantation of the murine embryo takes place on metestrus (Day 4.5), the equivalent of the late secretory phase in human. Another alternative for the study of embryo implantation are the in vitro models where different cell lines, primary cells, or tissue explants mimic both endometrium and embryo [28] . The selection of the appropriate cell lines is a fundamental issue to be considered because of differences in endometrial and trophoblast cell developmental stages [28] . In the current investigation, we employed an in vitro model of human implantation, where the endometrium was simulated using the RL95-2 cell line that has been reported to maintain the epithelial polarization, express adhesion molecules, and microfilaments in the apical surface and to be responsive to hormones and secretion of cytokines [29] . The breast carcinoma epithelial cells MCF7 were also employed in our investigations to observe if trophoblasts were able to interact with another epithelial cell line. MCF7 maintain epithelial cell characteristics and are responsive to hormonal stimulation; hence, they were used as another hormone responsive reproductive tissue from a nonendometrial origin [30] . The human embryo was simulated with multicellular spheroids from the choriocarcinoma trophoblast cell line JAr. This cell line has been employed in different studies for its ability to establish adhesive interactions with endometrial cell lines in short periods of coincubation [31] .
In the current investigation, we determined if the activation of the TLR 2 could influence the implantation of the embryo. The problem was explored using two different approaches. Initially we used an in vivo murine embryo implantation model to assess if the activation of TLR 2/6 in the UH affects uterine morphology and secretory profile during implantation period as well as embryonic implantation. Thereafter, we corroborated these observations in an in vitro human implantation model. In summary, the activation of TLR 2/6 in vivo decreased the murine embryo implantation rate with significant changes in tissue morphology and protein secretion. In addition, the in vitro adhesion of trophoblast spheroids to the endometrial cells was affected specifically by the activation of the endometrial TLRs.
MATERIALS AND METHODS

Embryo Transfer Experiments
Mice superovulation and mating. C57/CBA mice were obtained from Harlan Laboratories. All the mice used in the experiments were housed under controlled temperature conditions of 228C with a 14L:10D cycle, 40%-60% relative humidity, and free access to water and food. Females were kept in cages of 1000 cm 2 in groups of 8-10. Males were kept individually in 250 cm 2 cages. All the animal experiments were performed in accordance with Institutional Animal Care and Use Committee guidelines from the INIA (Instituto Nacional de Investigación y Tecnología Agraria y Alimentaria) and in adherence with guidelines established in the Guide for Care and Use of Laboratory Animals as adopted and promulgated by the Society for the Study of Reproduction. Females were injected intraperitoneally (i.p.) with 7.5 international units of equine chorionic gonadotropin (Foligon 500; Intervet), followed 48 h later by 7.5 international units of human chorionic gonadotropin (Veterin Corion; Equinvest). Thereafter, each female was placed in a male cage (2:1) for mating. On the next day (Day 0.5, 800-1000 h), the females with vaginal plugs were separated from the males. The selected mice were euthanized by cervical dislocation 3.5 days postmating (embryos reached blastocyst stage). Both uterine horns (UHs) were dissected and placed in a Petri dish in prewarmed M2 media (M7167; Sigma). The lumen of each horn was rinsed with M2 media using a 1 ml syringe with a 30 gauge needle. The blastocysts were collected under a stereoscopic microscope using a glass micropipette and rinsed twice in M2 media. Finally, they were rinsed once in prewarmed K þ -modified simplex optimized medium (ZEKS-050; Zenith Biotech) for at least 30 min until embryo transfer. The blastocysts were rinsed in warmed M2 media and placed in a transfer pipette.
Foster mice preparation. The foster CD1 mice were obtained from Harlan Laboratories. The females bedding was replaced with male bedding to initiate the estrous cycle. At the start of the estrus phase of the cycle (2 days later), the females were mated with vasectomized males to induce the pseudopregnancy state and prepare the reproductive tract to receive the embryos. The foster pseudopregnant mice were selected by the presence of a vaginal plug. On Day 3.5 postmating, females were anesthetized by inhalation of isofluorane and kept on a warm plate during the surgery. The left UH was exposed and the top of the uterotubal junction was carefully pierced with the tip of a 30 gauge needle where a transfer pipette loaded with the blastocysts was inserted. The pipette reached the UH through the opened uterotubal junction and delivered the blastocysts. The foster mice were kept in separate cages with tags, identifying the date of embryo transfer, number of embryos transferred, and treatment. Food and water were supplied ad libitum.
Histological Evaluation of the Murine UHs
Sample collection and storage. The foster mice were euthanized by cervical dislocation. UHs were dissected and placed in Petri dishes. The UHs were stored in 10% paraformaldehyde and dehydrated in a series of ethanol dilutions (70%, 90%, and 100%) for fixation. Finally UHs were sectioned in two and embedded in paraffin. The paraffin blocks were cut in transversal sections of 4 lm using a microtome and fixed to normal microscope slides. The sections on the slides were then stained using the conventional hematoxylin and eosin (H&E) method. Briefly, wax was removed by rinsing twice in xylene for 5 min. Tissue was hydrated in series of ethanol dilutions (twice in 99%, 95%, and 70%) and tap water for 5 min. The slides were stained with Gill II hematoxylin (VWR) for 1 min and rinsed with tap water for 3 min. The slides were stained in 1% aqueous eosin (VWR) with 1% calcium carbonate (Sigma) for 5 min and rinsed in tap water for 30 sec. The sections were dehydrated in serial dilutions of ethanol (70% and 95% for 10 sec and twice in 99% for 30 sec) and twice in xylene (1 and 3 min). Finally, the coverslip was fixed with DPX mountant (VWR).
The cross-sections in the slides were imaged using an Olympus CKX41 light microscopy and captured with the NIS elements software (version F3.0 SP4; Nikon). The changes of the development of the uterine decidua due to estrus cycle were observed.
Morphometric analysis of the UH. The images of 10 cross-sections were captured using the 203 objective and measured using the software ImageJ (National Institutes of Health). This step was taken to ensure the consistency of the measurements along the length of the horn. The scale for ImageJ area measurements was set using the scale bar (500 lm) given by the capture software. Each respective area was measured by outlining it with the free-hand selection tool and the area obtained using the measure option. For each UH cross-section, the total area (A T , i.e., myometrium, endometrial stroma and epithelium, and lumen), endometrial area (A el , including lumen), and luminal area (A L ) were measured and the number of glands (nG) was counted. The SANCHEZ-LOPEZ ET AL. endometrial area (A E ) and the myometral area (A M ) were calculated as follows:
Then the myometral index (M i ), endometrial index (E i ), luminal index (L i ), and gland index (G i ) were calculated as follows:
Cytokine Measurement
Sample collection and storage. The foster mice were euthanized by cervical dislocation. Uterine horns were dissected and placed in Petri dishes. The UHs were rinsed with 200 ll of M2 media using a 1 ml syringe. The media was collected in 0.5 ml centrifuge tubes and stored at À808C. The samples were incubated overnight with the membranes and the detection antibodies at 88C on a rocking platform. The membranes were rinsed with wash buffer consisting of a concentrated solution of buffered surfactant with preservative (catalog no. ARY006; R&D Systems) twice for 10 min and incubated with 2 ml of streptavidin-horseradish peroxidase for 30 min. The membranes were rinsed twice in wash buffer, and 0.5 ml of chemiluminescent reagent was used to develop the array. Images of the membranes were captured in an image analyzer after 5 min exposure.
Cytokines and chemokine quantification. The chemokine MCP-1 and cytokine IL-1b were evaluated in the UH flushing samples by flow cytometry using a Cytokine Bead Array (CBA) (BD Biosciences). Briefly, 50 ll of the flushed media samples were incubated with 50 ll of different cytokine detection beads mix and 50 ll of the phycoerythrin detection reagent and incubated for 3 h. The samples were washed with 300 ll of the provided wash buffer and centrifuged at 200 3 g for 5 min. The pellets were resuspended in 300 ll of wash buffer and analyzed in a FACSArray cytometer (BD Biosciences). The cytokine IL-1RA was measured using an enzyme-linked immunosorbent assay (ELISA) kit (PeproTech). Briefly 100 ll of the flushed media samples were incubated at room temperature in the anti-IL-1RA antibody precoated 96-well plate for 2 h. The plate was rinsed four times with washing buffer, and 100 ll of the secondary biotinylated antibody (500 ng/ml) was added and coincubated for 2 h. The plate was rinsed four times with the washing buffer, and 100 ll of the avidin peroxidase (1:200) was added and incubated for 30 min. Finally, the plate was rinsed four times with washing buffer and 100 ll of the 2,2 0 -azino-bis[3-ethylbenzothiazoline-6-sulphonic acid] liquid substrate was added. The optical density was measured in a plate reader at 405 nm with wavelength correction set at 650 nm.
In Vitro Adhesion Assay of Trophoblast Spheroids to the Endometrial Cells
Epithelial cell lines culture. RL95-2 cells were cultured in T75 flasks at 378C in Dulbecco-modified Eagle medium (DMEM)/F-12 (Sigma) supplemented with 1% penicillin/streptomycin (P/S) (Sigma), 5 lg/ml human recombinant insulin (12585-014; Gibco Invitrogen), 1% L-glutamine (Sigma), and 10% fetal bovine serum (FBS) (Sigma) at 378C in 5% CO 2 atmosphere until reaching confluency.
MCF7 cells grown in DMEM/F-12, supplemented with 10% FBS, 1% P/S, 1% L-glutamine, and 160 ng/ml insulin in a T75 flask at 378C in 5% CO 2 . At confluency, cells were washed with Dulbecco PBS (Sigma), harvested using trypsin-ethylenediaminetetraacetic acid (EDTA) (Sigma) and pelleted by centrifugation at 300 3 g for 4 min. Approximately 5 3 10 5 RL95-2 cells and 2.5 3 10 5 MCF7 cells were transferred to each well of a 12-well plate and incubated at 378C for 3-4 days.
Formation of JAr cells spheroids. JAr cells were grown in RPMI 1640 (Sigma) supplemented with 10% FBS, 1% P/S, and 1% L-glutamine in a T75 flask at 378C in 5% CO 2 . At confluency, cells were washed with Dulbecco PBS (Sigma), harvested using trypsin-EDTA (Sigma) and pelleted by centrifugation at 300 3 g for 4 min. To mimic the blastocyst, multicellular spheroids were formed from the JAr cells. One million JAr cells were counted with a hemocytometer and transferred to 5 ml of supplemented RPMI media in 60 3 15 mm Petri dishes. The spheroids were formed when the cell suspension was spun overnight on a MTS 2/4 digital gyratory shaker (JKA) at 280 rpm in a humid atmosphere and 5% CO 2 Adhesion of JAr spheroids to endometrial cells. Fifty JAr spheroids were picked and gently delivered to each well of a 12-well plate with a confluent monolayer of the epithelial cells. They were cocultured in supplemented DMEM/ F12 at 378C and 5% CO 2 . After coincubation, the initial number of JAr spheroids was confirmed by visual examination under a stereoscopic microscope. To remove nonadherent JAr spheroids from the epithelial cell monolayers, the 12-well culture plate was washed using a horizontal shaking device (Labman Automation LTD). The plate was incubated for 4 min at 200 rpm, and the media was discarded. Each well was filled with 1 ml of PBS containing Ca 2þ and Mg 2þ (mix from Gibco Invitrogen) and then set to shake for 4 min at 200 rpm. Finally, the PBS containing Ca 2þ and Mg 2þ was discarded. The final number of spheroids was counted under the microscope, and the results expressed as the percentage of spheroids from the initial number of spheroids counted before washing.
Viability assessment of the epithelial cells. The RL95-2 and MCF7 cells were grown in 12-well plates until they reached total confluence. The media was replaced with serum-free media before they were either activated or not with PGN and FSL-1 (Invivogen). The cells were harvested with 50 ll of trypsin-EDTA to detach them from the wells, collected in 500 ll of media and pelleted by centrifuging at 300 3 g for 5 min. The cells were then resuspended in 200 ll of PBS and divided in two 5 ml cytometry tubes. One sample was used to determine its autofluorescence and the other was stained with 3 lM propidium iodide (PI) (Life technologies) and captured immediately. The samples were read in a FACSCalibur cytometer (BD Biosciences) capturing 1 3 10 4 events and the percentage of PI-positive events (dead cells) was registered. The results are expressed as percentage of live cells and were compared using a one-way ANOVA; P , 0.05 was considered significant.
Evaluation of the Murine UH after TLR 2/6 Activation
Morphological and morphometrical assessment and evaluation of the UH protein secretion after TLR 2/6 activation. The foster Swiss mice were mated with vasectomized males to induce the pseudopregnancy state. On Day 3.5 postmating, the uterotubal junction of the left UH was pierced with the tip of a 30 gauge needle, and a transfer pipette was inserted through the opening to deliver 10 ll of FSL-1 (0.1 lg/ll; n ¼ 16) or saline solution as a control group (n ¼ 10). Mice were sacrificed 4 h later (preimplantation day) or on Day 4.5 (implantation day), and the UHs were collected. The inflammatory reaction in the UH was assessed by morphological and morphometric evaluation of the H&E-stained samples. The flushed media samples from the UHs were pooled in four different groups: Ctrl 4 h, FSL-1 4 h, Ctrl 24 h, and FSL-1 24 h. The protein production was assessed using the semiquantitative Mouse Cytokine Array Panel A kit (R&D Systems) for the presence of 40 different cytokines. The profile of protein production was compared between the experimental groups. Furthermore, the concentrations of the cytokines IL-1b and MCP-1 were assessed in each individual sample by CBAs and IL-1RA with an ELISA kit, and the data were log transformed to normalize distribution.
Evaluation of the effect of TLR 2/6 activation on embryo implantation. The Swiss foster mice were prepared for embryo transfer as mentioned above. The uterotubal junction of the left UH in each mice was pierced with a 30 gauge needle to make an opening and, using a transfer pipette, infused with a drop of 10 ll of saline solution (n ¼ 15) or FSL-1 (0.1 lg/ll; n ¼ 16) followed by a gap of air and a drop containing the 12 blastocysts. After 15 days, the foster mice were euthanized by cervical dislocation. The UHs were dissected, and the number of embryos implanted and fetuses resorbed was registered (Fig.  1) .
TLR ACTIVATION AFFECTS UTERINE RECEPTIVITY
Effect of the Activation of Epithelial TLR 2 and TLR 2/6 on the Adhesion of Trophoblast Spheroids Adhesion of trophoblast spheroids to epithelial cells treated with different concentrations of TLR 2 and 2/6 ligands. To determine whether TLR 2 and TLR 2/6 activation is affecting the trophoblast adhesion to the epithelial cells, we evaluated the effect of different concentrations of PGN and FSL-1 on the epithelial cells. The RL95-2 and MCF7 cells were grown in 12-well plates until total confluence. The media was replaced with serum-free media before they were either activated or not with PGN and FSL-1 (Invivogen). The epithelial cells were then stimulated with different concentrations of PGN (0, 5, 10, and 20 lg/ml) or FSL-1 (10, 100, and 200 ng/ml) for 24 h. JAr spheroids were delivered onto the confluent monolayers and coincubated for 1h. Adhesion was assessed as described before.
Adhesion of trophoblast spheroids to stimulated epithelial cells at different time intervals. To understand if coincubation duration is affecting the outcome of trophoblast binding to the epithelial cells, the cells were preincubated with 10 lg/ml of PGN or 100 ng/ml of FSL-1 for 24 h. Thereafter, 50 JAr spheroids were delivered onto the confluent epithelial cell monolayers in 12-well plates and coincubated for 0.5, 1, 2, or 4 h. The adhesion was assessed as described before.
Effect of the inhibition of epithelial TLR activation on trophoblast spheroid adhesion. To understand the effect of TLR 2 inhibition in endometrial cells on trophoblast spheroids binding to endometrial cells, the epithelial cells were either pretreated or not with a monoclonal antibody against TLR 2 (2 lg/ml neutralizing immunoglobulin A monoclonal; Invivogen) or anti-TLR 6 monoclonal antibody (10 ng/ml mouse immunoglobulin G1; Invivogen) 1 h before the addition of PGN (5 lg/ml) or FSL-1 (10 ng/ml) respectively. After 24 h, 50 JAr spheroids were delivered onto the monolayer and coincubated for 30 min. Nonadherent spheroids were removed, and the percentage of adhered spheroids was determined.
The effect of TLR activation on the viability of the epithelial cells. To determine whether TLR 2 and TLR 2/6 activation is affecting the viability of the epithelial cells; we treated the cells with different concentrations of PGN and FSL-1. The epithelial cells were then stimulated with different concentrations of PGN (0, 5, 10, and 20 lg/ml) or FSL-1 (10, 100, and 200 ng/ml) for 24 h. The viability of the cells was verified by PI staining in the FACSCalibur cytometer.
Statistical analysis
The results were expressed as mean 6 SEM. Statistical analysis was performed using Statistica, version 7 (Statsoft). The comparison of two experimental groups was performed with the nonparametric Mann-Whitney Utest. The concentration of the cytokines measured by CBA and ELISA were log transformed to normalize their distribution. Multiple groups were compared with a one-way ANOVA and a Bonferroni multiple comparison posttest. The effects of FSL-1 and PGN treatments on the coincubation kinetics were compared with a two-way ANOVA test and a Bonferroni posttest to compare effects between nonstimulated control and treated cells. P 0.05 was considered to be significant.
RESULTS
Local FSL-1 Administration in Uterus Induced Morphological Changes in UH
The saline-treated UHs on the preimplantation day (4 h posttreatment) retained the morphology of a normal UH. The myometrium was dense, and endometrial stroma filled with secretory glands. The endometrial lumen was pseudostratified and convoluted, showing a small luminal space. Finally, an abundant secretory activity in the endometrial luminal cells and glands could be observed ( Fig. 2A) . In contrast to this, the FSL-1 treated UH presented an atrophic morphology. The thickness of the myometrium and stroma was reduced as well as the number of glands observed. The FSL-1 treated epithelial endometrial cells morphology changed from columnar pseudostratified to simple columnar/cuboidal shape. Nevertheless, some secretory activity could still be observed (Fig. 2A) . The Mi, Ei, and Gi were significantly higher in the saline group compared to the FSL-1 treated group (Fig. 2B) . In contrast, the lumen was smaller and more convoluted in the saline than in the FSL-1 treated group (Fig. 2B) . In controls, the morphology of the UHs on the implantation day (24 h posttreatment) was similar to the ones at estrus. In addition to this, the stroma was loose and filled with edema, a characteristic of a decidualized endometrium. The presence of vacuoles in the cytoplasm of luminal and glandular epithelial cells confirmed high secretory activity at this stage. The 24 h FSL-1 treatment induced an atrophia of the UHs decidua (Fig. 2C ). This could be observed in the reduction of the Mi and Ei of the FSL-1 treated UHs compared to the saline-treated UHs (Fig. 2D) .
FSL-1 Treatment of the UHs Increased the Production of Proinflammatory Cytokines
Sixteen proteins were detected 4 h after treatments and 17 proteins were detected 24 h after treatments in the cytokine array. The FSL-1 treatment of the UH on the preimplantation day increased the production of TNF-a, TIMP-1, MCP-1, M-CSF, KC, IL-16, IL-1ra, IL-1b, and IFN-c (Fig. 3A) . Among these proteins, the highest difference between FSL-1 and saline treatments was observed in MCP-1, IL-1ra, and IL-1b. FSL-1 treatment for 24 h increased significantly the production of MCP-1, IL-17, IL-16, IL-13, IL-7, IL-4, IL-1ra, IL-1b, IL-1a, and C5a (Fig. 3B) . Based on these analyses, each individual sample was analyzed again by CBA for the production of IL1b and MCP-1 and by ELISA for IL-1RA. The FSL-1 treatment of the tissue for 4h considerably increased the production of IL-1b and MCP-1; however, the change in IL-1RA production was minimal (Fig. 3C) . The production of IL1b and MCP-1 after 24h of FSL-1 treatment was lower, and no difference was observed between the different treatments. In contrast, this treatment significantly increased IL-1RA production (Fig. 3D) .
Activation of TLR 2/6 in the Murine UH Affects Embryo Implantation
The activation of TLR 2/6 with FSL-1 severely reduced the number of total implantations in the UH compared to the saline-treated horns (45.00% 6 6.49% vs. 16.69% 6 5.01%, P , 0.05; Fig. 4A ). The number of total implantations included the embryos that developed to fetuses and those that were resorbed (i.e., implanted embryos that could not develop; Fig.  4B ). The percentage of developed fetuses decreased after the administration of FSL-1 to the UH (45.56% 6 6.79% vs. 26.04% 6 6.84%, P , 0.05; Fig. 4C ). On the other hand, we observed an increase in the percentage of resorbed fetuses in the FSL-1 treated group compared to the saline group (4.44% 6 1.79% vs. 14.17% 6 3.45%, P , 0.05; Fig. 4D ).
The Activation of Epithelial TLR 2 and 2/6 Decreased the Adhesion of Trophoblasts Spheroids In Vitro Regardless of the Coincubation Time
The trophoblast spheroids adhered to the cells as soon as 30 min after their introduction to the wells, and this adhesion was always higher in the RL95-2 cells than for MCF7 cells (63.4% 6 4.38% vs. 37.35% 6 3.02%). The effect of the treatment of the epithelial cells with 100 ng/ml of FSL-1 for 24 h on the adhesion of the JAr spheroids was significant for RL95-2 (P , 0.05) and MCF7 cells (P , 0.0001) as well as the effect of the coincubation time (P , 0.0001 for RL95-2 and P , 0.0001 for MCF7). The FSL-1 stimulation was consistent throughout the time because no interaction was observed in both cell lines (P ¼ 0.6473 for RL95-2 and P ¼ 0.8718 for MCF7 cells; Fig. 5, A  and B) . The JAr spheroid adhesion was found to be significantly different between the nonstimulated control and FSL-1 stimulated MCF7 cells at 30 min (37.35% 6 3.02% vs.
26.56% 6 2.59%, P , 0.01) and 4 h (73.01% 6 2.23% vs. 62.28% 6 2.053%, P , 0.01). The treatment of the cells with PGN was also consistent throughout the stimulation time because no interaction was observed (P ¼ 0.5527 for RL95-2 and P ¼ 0.5663 for MCF7). We observed a significant effect of the treatment of the cells with 10 lg/ml of PGN on the adhesion of JAr spheroids adhered in both RL95-2 (P , 0.0001) and MCF7 cells (P , 0.0001). The effect of time on the adhesion of the spheroids was also found to be significant in both cell lines (P , 0.0001 for both RL95-2 and MCF7; Fig.  5, A and B) . The adhesion of the JAr spheroids to the nontreated RL95-2 cells differ significantly from the PGN treated cells at 1 h (73.79% 6 2.85% vs. 64.1% 6 3.9%, P , 0.05) and 2 h of coincubation (89.05% 6 2.02% vs. 76.39% 6 2.54%, P , 0.01). The same effect was observed in the MCF7 cells at 1 h (73.01% 6 2.43% vs. 67.95% 6 3.23%, P , 0.05) and 2 h of coincubation with the JAr spheroids (84.19% 6 3.11% vs. 71.34% 6 4.26%, P , 0.01).
Trophoblast Spheroid Decreased Adhesion to the Epithelial Monolayer Was Proportional to the TLR Ligand Concentration
The 24 h stimulation of RL95-2 and MCF7 cells with 100 and 200 ng/ml of FSL-1 (68.11% 6 4.83% and 61.07% 6 4.52% for RL95 and 41.66% 6 2.82% and 40.21% 6 3.36% for MCF7) significantly decreased the adhesion of the JAr spheroids to the monolayer compared to the nonstimulated control (83.46% 6 2.685%, P ¼ 0.0012, for RL95 and 58.58% 6 2.43%, P , 0.0005, for MCF7) after 1 h of coincubation (Fig 6, A and B) . A similar effect was observed with PGN stimulation. The RL95-2 stimulation with 20 lg/ml PGN significantly decreased JAr spheroid adhesion compared to the nonstimulated control (57.09% 6 3.83% vs. 72.92% 6 3.74%, P , 0.05; Fig. 6A ). In MCF7, 5, 10, and 20 lg/ml of PGN significantly decreased JAr spheroid adhesion (57.05% 6 3%, 47.04% 6 1.23%, and 50.19% 6 2.86%, respectively) compared to the nonstimulated control (68.25% 6 2.71%, P , 0.0001; Fig. 6B ). 
TLR ACTIVATION AFFECTS UTERINE RECEPTIVITY
The Pretreatment of the Endometrial Cells with TLR Blocking Antibodies Could Restore the Spheroid Adhesion
We confirmed the specificity of the TLR effect by blocking their activation with monoclonal antibodies. The pretreatment with a monoclonal anti-TLR 6 antibody followed by FSL-1 stimulation restored the percentage of adhered JAr spheroids to RL95-2 cells (59.71% 6 1.91%) and MCF7 cells (30.70% 6 4.54%) compared to nontreated cells (63.26% 6 2.74% and 31.48% 6 4.087%, respectively; Fig. 7, A and B) . The pretreatment of the epithelial cells with a monoclonal anti-TLR 2 blocking-antibody before the PGN stimulation allowed JAr spheroids to adhere to the monolayer to similar levels (58.15% 6 4.14% for RL95-2 and 33.15% 6 4.44% for MCF7) to those observed in the nonstimulated control (61.81% 6 2.65% for RL95-2 and 35.01% 6 3.78% for MCF7; Fig. 7, A and B) . The treatment with the antibodies did not show an effect on the adhesion of JAr spheroids to the monolayers (anti-TLR 6: 63.35% 6 2.48% for RL95-2 and 33.08% 6 4.28% for MCF7; anti-TLR 2: 61.96% 6 3.25% for RL95-2 and 36.72% 6 2.45% for MCF7) whereas the stimulation with FSL-1 and PGN decreased significantly the adhesion of the JAr spheroids (FSL-1: 45.70% 6 1.91%, P , 0.0001, for RL95-2 and 18.20% 6 3.66%, P , 0.0005, for MCF7; PGN: 45.34% 6 3.51%, P , 0.0001, for RL95-2 and 24.00% 6 2.87%, P , 0.0001, for MCF7).
The Viability of the Epithelial Cells Was Unaltered after TLR Activation
The stimulation of the RL95-2 and MCF7 cells with both FSL-1 and PGN did not affect the viability of the cells. Around 90% of the nonstimulated cells remained viable after harvesting from the wells. The viability of the cells stimulated with FSL-1 or PGN was also around 90% of the total population (Fig. 8) .
DISCUSSION
Embryo implantation is a complex event initiated by the adhesion of the trophectoderm to the endometrial epithelial cells. This is followed by the trophoblast invasion into the uterine decidua. Two major factors are involved in a successful implantation, a good quality embryo and proper endometrial The adhesion of the spheroids to endometrial untreated cells ( ) was compared to the endometrial cells treated (&) with 100 ng/ml FSL-1 or 10 lg/ml PGN. Each point represents the mean 6 SEM of four independent experiments treatments were compared by a two-way ANOVA to test interaction between effects, treatment, and coincubation time. Furthermore the difference between control and treated groups per individual time points was assessed with a Bonferroni multiple comparisons posttest (*P 0.05 was considered significant).
SANCHEZ-LOPEZ ET AL.
receptivity. Any disturbance in the intricate cross-talk of hormones, cytokines, and adhesion factors during this critical period could lead to implantation failure [32, 33] .
In our study using an in vivo murine model, we explored the characteristics of the UH on preimplantation and implantation day. We were able to create an inflammatory environment in the UH by stimulating the innate immune system via a TLR 2/6 ligand and observe how it could affect the tissue structure and impair embryo implantation. The inflammatory insult in the UH strongly affected the architecture of the different layers of the tissue. This effect could be observed as soon as 4 h after the FSL-1 administration, when the endometrium is remodeling for suitable embryo receptivity. This might indicate that the epithelial and stromal cells of the uterus are sensitive to innate immune activation via TLR stimulation as a protective mechanism for the mother. Stromal cells have been found necessary to mediate immune responses in different body tissues. They offer a substrate for the migrating leukocytes and orchestrate part of the adaptive immune responses [34] . During embryo implantation, the uterine stromal cells provide a scaffold for migrating cytotrophoblasts and establishment of the spiral arteries. The stromal sensitivity to respond to inflammatory stimuli has been studied, where administration of i.p. poly I:C (TLR 3 ligand) to mice affects stromal decidualization and vascularization of the uterus [35] . In our experiments, the innate immune activation was performed via FSL-1, which is a synthetic diacyl lipopeptide specific ligand for TLR 2/6 [36] . It is possible that the effect on the tissue remodeling will occur regardless of the type of TLR activated. In fact, the capacity of the endometrial cells to react to foreign entities has been assessed previously where the exposure of the UH to the toxic compound di-(2-ethylhexyl)-phthalate is able to affect tissue decidualization and impair embryo implantation [37] . The current methods to evaluate the estrogenic effects of toxic compounds on the UH is based on the uterotrophic assay developed in the 1930s. It estimates the weight of the horns after treatment and gives a description of the morphological characteristics of the uterine layers and cells [38] . In humans, the criteria to date the endometrium based on pathologist observations were established by Noyes in the 1950s. It estimates scores for the different morphological changes of the endometrial characteristics in gland, epithelia, and stromal development as a result of the phase of the cycle [39] . In our morphometric assessment, we were able to measure accurately TLR ACTIVATION AFFECTS UTERINE RECEPTIVITY the areas of the different UH compartments with the help of the digital imaging tools. Also the possible differences due to horn size and sampling along the length of the horn were normalized with the calculation of the indexes. This technique can potentially be used as an effective method of estimating toxic effects of chemical compounds on the UH of different mammalian species, although more standardization in its validity is required.
The implantation as mentioned before is an agreement between the maternal tract and the embryo. Cytokines produced by the maternal tract are fundamental effectors, which also peculiarly resemble an inflammatory reaction. By profiling the UH secretions, we were able to observe a disruption in the cytokine levels when the uterine TLR 2/6 was activated. After 4 h of stimulation (preimplantation day), three proteins were up-regulated: MCP-1 (CCL2), IL-1b, and IL-1ra. The three of them share important roles in both embryo implantation and in inflammation. The stimulation of the endometrium epithelia with IL-1b has been found to induce the expression of endometrial adhesion molecules necessary for embryo apposition and adhesion [40] . MCP-1 has been proven to be inducible by in vitro stimulation of TLR 2/6 in murine uterine epithelial cells and TLR4 in uterine epithelial and stromal cells [41] . The increase in IL-1RA production after 24 h of TLR 2/6 stimulation could interfere with the embryomother cross-talk, thereby antagonizing IL-1b. The i.p. administration of IL-1RA to mice in the preimplantation period reduces drastically embryo implantation [42] . After 24 h of FSL-1 treatment, we observed a distinctive change in pattern of expression of cytokines toward a Th17 response, which can lead to autoimmune diseases, chronic inflammatory disorders, and infectious diseases [43] . In the endometrium, they have been associated with cases of unexplained infertility [44, 45] as well as in the response to Chlamydia muridarum, the murine homologue of C. trachomatis [46] . This pathogen can initially be recognized by TLR 2 prior to an adaptive response [16] .
The reduction of embryo implantation confirmed a direct effect of the activation of uterine TLR 2/6 on embryo implantation. This activation was able to affect the development of the uterine tissue and the secreted protein profile necessary for implantation. As observed, the lack of a receptive epithelium to adhere would affect the apposition and adhesion FIG. 7 . Effects of the inhibition of epithelial TLR 6 and TLR 2 activation on the adhesion capacity of the JAr spheroids. The RL95-2 (A) or MCF7 (B) cells were pretreated or not with an anti-TLR6 immunoglobulin G antibody (10 ng/ml) or monoclonal anti-TLR-2 immunoglobulin A antibody (2 lg/ml) and stimulated with FSL-1 (10 ng/ml) or PGN (10 lg/ml), respectively. The percentage of adhesion to the nontreated or different treated groups was assessed. The data represents the mean of three independent experiments 6 SEM. A multifactorial ANOVA with Bonferroni multiple comparison test was used to compare the different groups (*P , 0.05).
of the blastocyst. It might be possible that the molecular characteristics of the endometrial cells could be also affected by this stimulation. It is unlikely that the treatment of the UH with the TLR 6 agonist could harm the embryos and could be the reason of embryo implantation loss. A previous report has demonstrated that the first trimester trophoblast lack the expression of TLR 6 and stimulation does not change blastocyst viability [47] . The FRT has been shown to be sensitive to TLR stimulation in vivo, for example, the infusion of lipopolysaccharide to the murine UH induces a TLR 4-dependent inflammatory pelvic disease [48] . It has also been observed that the administration of i.p. lipopolysaccharide to mated mice on Day 5.5 could increase fetal loss [49] . The atrophic stroma observed after TLR 2/6 stimulation would offer a deficient soil for the embryo to invade and start its development. This is likely to be a contributing factor for the increase in embryo resorption observed in our investigation. Similar to this study, it has been observed that after the administration of i.p. poly I:C, TLR 3 ligand can decrease the implantation rate and increase the percentage of resorbed embryos by impairing stromal decidualization and spiral arteries development [35] . Hence, a potential reason for the low success rate of implantation after embryo transfer is the simple manipulation of the UH or endometrium during embryo transfer procedures in human or livestock that could damage the tissue. This damage could induce a sterile inflammatory process by the release of danger-associated molecular pattern molecules that are also recognized by the TLRs, initiating an inflammatory process and leading to embryo implantation failure. A potential way of clarifying these effects on the murine UH and a future scope of our research is to use a TLR6 knockout mouse. In this way, we would be able to test the effects of TLR activation on both tissue structure and embryo implantation.
To corroborate our observations in the murine model of embryo implantation, we used an in vitro human trophoblast spheroid adhesion model as mentioned before. The percentage of spheroids adhered increased proportionally with time, as observed previously [50, 51] . The JAr cells have been described as a very invasive choriocarcinoma cell line [50] . The interaction of MCF7 cells with first trimester placental explants has been observed before. The trophoblast explants affected MCF7 proliferation and induced apoptosis in long coincubation times [52] . Our experiments were carried out for short coincubation times where we were able to observe adhesion of trophoblast to both epithelial cells. Nevertheless, a TLR ACTIVATION AFFECTS UTERINE RECEPTIVITY better interaction was observed with the endometrial cells because trophoblast cells adhered to them in a higher percentage and faster than the MCF7 cells.
Stimulation of TLR 2 and 2/6 in the epithelial cells decreased the percentage of attached spheroids to the monolayers. It is unclear how the TLR activation can influence endometrial receptivity. The fact that we observed a decrease in trophoblast spheroid adhesion in both epithelial cell lines after TLRs activation might suggest that the TLR activation effect relies on modification of cellular adhesion capability. Expression of surface adhesion molecules, cell polarity, or even cytoskeletal arrangement necessary for the cell-cell interactions might be involved. In our study, it was clear that the decrease in trophoblast adhesion to epithelial cells came from the TLR activation on the epithelial cells. The inhibition of TLR 6 and TLR 2 with specific antibodies restored the ability of the JAr spheroids to bind to both FSL-1 and PGN stimulated RL95-2 cells. It is important to consider that TLR 2 is a particular receptor of the TLR family. It can form homodimers and heterodimers with either TLR 1 or TLR 6, increasing the range of ligands that TLR 2 can recognize, from bacterial PGN to diacyl and triacyl lipopeptides [53, 54] . TLR 2/6 functionality is dependent on the dimerization and the recognition of the ligand by both TLRs. If one of them is absent, then the activation by the diacylated lipopeptides will not occur [19, 55] . A previous report from our laboratory explored how the stimulation of TLR 5 with flagellin can induce a similar effect on the adhesion of trophoblast cells to endometrial epithelial cells [24] . Finally, as shown in our results (Fig. 8) , the decrease in spheroid adhesion to the endometrial cells cannot be attributed to the effect of the TLR stimulation on the viability of the cells. Together, these results suggest that the activation of TLRs will have a detrimental effect on implantation, and this might happen regardless of which TLR molecule is being stimulated.
Clinically, endometrial TLR 2 might be playing a very important role in the recognition of pathogens that cause STDs and infertility. The most common bacterial STD is caused by the intracellular obligate Gram-negative pathogen C. trachomatis. Chlamydia can cause a cervical infection that, if it ascends into the upper tract, can generate pelvic inflammatory disease and infertility [56] . Chlamydia can be recognized by TLR 2 in the intracellular inclusions and induce the production of IL-8 [16] . Furthermore, this recognition and the initiation of the immune responses is dependent on TLR 2 and not TLR 4, and mice lacking TLR 2 show a reduced oviductal inflammation [57] .
Determining the suitable endometrial conditions for the implantation of the embryo is a topic under constant research [2, 3, 5, 6, 33] . Correct diagnosis of the causes of infertility can increase significantly the success of pregnancy for women with fertility problems and couples undergoing in vitro fertilization treatment. With further research on the mechanisms responsible for the effects observed here, it could become possible to design and direct a therapy targeting the endometrial innate immune system to increase the implantation success. Our data support the importance of TLRs during the time of implantation, suggesting that they could be used as a potential target in the management of infertility cases.
